The Value of Adding Inclusivity Insights to Competitive Readiness Planning
Situation
A client gearing up to move into late-stage clinical development in multiple myeloma sought insights into how to optimize their chances of success.
Task
Develop a concise landscape analysis, including how well frontrunners are enrolling pivotal studies with patients that are reflective of the real-world patient population, and the implications of these patient demographics on their clinical outcomes and market access strategies.
Action
Compared the eligibility criteria details for each pivotal study and contextualize these in terms of their impact on the ability of traditionally-underrepresented patient populations to qualify, such as hematology laboratory criteria.
Analyzed what sponsors are sharing publicly on terms of their internal metrics and commitment to clinical trial diversity.
Identified leading indicators of each sponsor’s likelihood of effectively enrolling patient populations that reflect the real-world demographic of the disease, such as public-private partnerships, public policy positions and org charts.
Matched clinical trial sites with regional diversity indices.
Leveraged secondary intelligence to deduce which individual trial sites are most likely to already have the cultural competency and community-based infrastructure to support multiple touchpoints with traditionally-underserved communities.
Leveraged primary intelligence to understand how individual sites are addressing access issues, such as childcare, transportation, extended or flexible clinic hours and translation services.
Results
The client gained a roadmap of best practices for enrolling a clinical study in multiple myeloma that reflects the real-world demographic of patients in the US, positioning their therapy to win the competitive advantage in an increasingly diverse America and be readily-utilized by a broad, previously-untapped patient population.
Gained a roadmap
Elevated engagement
Built trust
Accessing the Entirety
of the Addressable Market
No items found.
Please note: images are for illustrative purposes only.
Related Case Study
Informing the Go-To-Market Strategy for a Targeted Therapy in NSCLC
By clicking "Accept cookies", you agree to storing cookies on your device to enhance site navigation, analyze site usage and assist in our marketing efforts as outlined in our privacy policy.
By clicking 'Accept all cookies', you agree to storing cookies on your device to enhance site navigation, analyze site usage and assist in our marketing efforts as outlined in our privacy policy.
